Laboratory Economics: Re-Valuation of 88305-PC Threatens Pathologists
The following timely article is reprinted with permission from Laboratory Economics, Jondavid Klipp, editor. We thank him for granting us the right to share valuable insights on this vital topic. Learn more about Laboratory Economics at www.laboratoryeconomics.com
CMS is very likely to review Medicare’s professional interpretation reimbursement rates for the entire surgical pathology code set (CPT 88300-88309) under its Potentially Misvalued Code Initiative. The review could result in big rate cuts to key pathology codes including CPT 88305-PC.
“This is the biggest potential threat to the practice of pathology that I’ve seen in my career,” warns A. Joe Saad, MD, Chair of the Council on Government and Professional Affairs at the College of American Pathologists.
CMS’s potential review of surgical pathology professional component (PC) reimbursement was triggered by a request from the Maryland Health Care Commission (MHCC – Baltimore, MD). MHCC is an independent state regulatory agency that publishes reports on health care pricing for lawmakers and insurance payers.
MHCC has prompted CMS to take a closer look at CPT 88305-PC reimbursement rates by submitting an empirical claims analysis showing that current physician time assumptions produce implausibly long workdays.
MHCC evaluated billing data provider-by-provider and day-by-day using Maryland’s All-Payer Claims Database from 2023. When the current assumed physician time, approximately 25 minutes for CPT 88305-PC, was applied to actual claims volume, MHCC identified instances in which the implied physician work time appeared to exceed the number of hours in a day.
For example, MHCC’s analysis of approximately 60,000 claims found that there were 1,763 provider-days where billings for CPT 88305-PC alone exceeded 8 hours of nominal time, and 587 provider-days where it exceeded 24 hours.
The MHCC study noted that dermatologists and gastroenterologists were billing for CPT 88305-PC, despite the code seeming to indicate this procedure is performed by a pathologist.
“Possibly drawn to lucrative valuation relative to how long it takes to perform the examinations in real life, it appears that dermatologists and gastroenterologists have established their own labs to capture the revenue that comes from reading their own skin biopsies and colonoscopy specimens. This could lead to perverse financial incentives to ‘over-biopsy,’ leading to potentially negative consequences for patient care,” according to MHCC.
Dr. Saad says there are at least five major problems with the MHCC study:
- The methodology and data for the study have not been made public.
- The study did not account for the wide heterogeneity of organ samples for which CPT 88305-PC can be billed. There are 65 different organ tissue types that require a wide range of pathologist time to interpret.
- Pathologists often do batch billing for a bunch of cases that were read over a period of 3-5 days.
- A single pathologist will often bill for themselves plus other pathologists in the group using a single NPI number.
- The study did not account for physician “intensity” of effort, including things like physician judgment, technical skill and the stress involved with rendering an interpretation.
Dr. Saad is hopeful that any CMS re-evaluation of the surgical pathology code set will be done using the traditional RVS Update Committee (RUC). The 32-member RUC is a multispecialty committee that utilizes physician surveys to determine the resources required to provide specific physician services.
Unfortunately, last year’s 2026 Physician Fee Schedule Final Rule demonstrated a marked departure in CMS’s strategy for how it intends to value services going forward. CMS stated that it will:
“preferentially consider empiric information submitted by interested parties […] We believe that robust empiric data is important to avoid some of the shortcomings of survey data in accounting for efficiencies over time.”
More details on the potential re-evaluation of the surgical pathology code are expected to be published later this year in the Medicare Physician Fee Schedule Final Rule for 2027.